Pathobiology 2027
Mechanisms of Disease
May 1-4, 2027
Flamingo Las Vegas, Las Vegas, NW
Session 020 – Biomarker Discovery Using Bioinformatics and Machine Learning
8:00-9:45 AM
Sponsored by the ASIP Molecular Diagnostic Pathology Scientific Interest Group
Session Room: TBD
Session Co-Chairs
Yu-Jui Yvonne Wan, PhD
University of California, Davis
Jingjing You, PhD
University of Sydney
Session Overview
This session focuses on biomarker discovery using modern technologies – bioinformatics and machine learning. We have speakers from a diverse background to present their findings on biomarker discovery via bioinformatics and machine learning. In this session, you will learn how these different tools have been used in biomarker research in different diseases and in the scenario of drug discovery.
Agenda
Co-Chair – Welcome and Introductions
8:00-8:25 AM
Integrative Biomarker Discovery in Hepatocellular Carcinoma Using Machine Learning
Yu-Chiao (Chris) Chiu, PhD
University of Pittsburgh
8:25-8:50 AM
Biomarker Discovery for Metabolic Diseases
Prasant Jena, PhD
Cedars-Sinai Medical Center
8:50-9:15 AM
Geometric Deep Learning for Drug Design and Patient Survival
Yu Guang Wang, PhD
Monash and University of New South Wales
9:15-9:40 AM
Biomarkers for Neuronal Degenerative Diseases
Yuhong Fu, PhD
University of Sydney